000
| 01990cam 2200289za 4500 |
---|
001 | 9.822989 |
---|
003 | CaOODSP |
---|
005 | 20221107143811 |
---|
007 | cr ||||||||||| |
---|
008 | 160819s2008 onca |o f|0| 0 eng d |
---|
040 | |aCaOODSP|beng |
---|
043 | |an-cn--- |
---|
086 | 1 |aH14-167/2008E-PDF |
---|
245 | 00|aInterdepartmental summative evaluation of the Canadian Regulatory System for Biotechnology |h[electronic resource] : |bfinal report. |
---|
246 | 17|aInterdepartmental summative evaluation of the CRSB |
---|
260 | |a[Ottawa] : |bHealth Canada, |c2008. |
---|
300 | |a[183] p. in various pagings : |bill., tables, photo. |
---|
500 | |aIssued also in French under title: Évaluation sommative interministérielle du Système canadien de réglementation de la biotechnologie : rapport final. |
---|
500 | |a"February 7, 2008." |
---|
500 | |a"Approved by Departmental Executive Committee on Finance, Evaluation and Accountability (DEC-FEA) Health Canada." |
---|
504 | |aIncludes bibliographical references. |
---|
520 | |aThis report presents the results of the interdepartmental summative evaluation of the Canadian Regulatory System for Biotechnology (CRSB). The purpose of the evaluation was to examine the continued relevance of the CRSB, the extent to which the initiative is achieving its objectives, its other impacts and effects, and whether there are more cost-effective ways of achieving the mandate and objectives of the CRSB. The evaluation covers the period from the inception of the CRSB to the present– i.e., fiscal years 2000-01 through 2005-06. The study was carried out over the period January through June, 2006. ... |
---|
692 | 07|2gccst|aBiotechnology |
---|
692 | 07|2gccst|aProgram assessment |
---|
710 | 1 |aCanada. |bHealth Canada. |
---|
775 | 08|tÉvaluation sommative interministérielle du Système canadien de réglementation de la biotechnologie |w(CaOODSP)9.822991 |
---|
856 | 40|qPDF|s870 KB|uhttps://publications.gc.ca/collections/collection_2016/sc-hc/H14-167-2008-eng.pdf |
---|